肿瘤|《细胞》子刊:红肉陷阱,竟是免疫治疗的神来之笔?复旦团队发现,肠菌代谢物TMAO能够加强三阴性乳腺癌患者对免疫治疗的反应( 三 )


[6]Adams, S., et al.(2019). Current landscape of immunotherapy in breast cancer: a review.
JAMA Oncol. 5, 1205–1214.
[7]Bianchini, G., et al (2016). Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat. Rev. Clin. Oncol. 13, 674–690.
[8]Schmid, P., et al. (2018). Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer. N. Engl. J. Med. 379, 2108–2121.
[9]Nejman, D.,et al. (2020). The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science 368, 973–980.
[10]Jiang, Y.-Z., et al. (2019). Genomic and tranomic landscape of triplenegative breast cancers: subtypes and treatment strategies. Cancer Cell 35, 428–440.e5.
[11]Wang, Z., et al. (2015). Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 163, 1585–1595.
本文作者 | 张艾迪